These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31138944)

  • 1. Presentation and survival of multiple myeloma patients in Ghana: a review of 169 cases.
    Acquah ME; Hsing AW; McGuire V; Wang S; Birmann B; Dei-Adomakoh Y
    Ghana Med J; 2019 Mar; 53(1):52-58. PubMed ID: 31138944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting outcome of patients with multiple myeloma.
    Basit A; Siddiqui N; Hameed A; Muzaffar N; Athar S
    J Ayub Med Coll Abbottabad; 2014; 26(3):376-9. PubMed ID: 25671952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features and survival of Chilean patients with multiple myeloma].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2007 Sep; 135(9):1111-7. PubMed ID: 18064364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUSCULOSKELETAL PRESENTATION OF MULTIPLE MYELOMA AT GENERAL HOSPITAL DOUALA, CAMEROON.
    Doualla-Bija M; Ndongho EN; Oben DT; Namme HL; Mbanya D
    East Afr Med J; 2014 Sep; 91(9):311-6. PubMed ID: 26866083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies.
    Zagouri F; Kastritis E; Zomas A; Terpos E; Katodritou E; Symeonidis A; Delimpasi S; Pouli A; Vassilakopoulos TP; Michalis E; Giannouli S; Kartasis Z; Christoforidou A; Kokoviadou K; Hatzimichael E; Gika D; Megalakaki C; Papaioannou M; Kyrtsonis MC; Konstantopoulos K; Dimopoulos MA;
    Eur J Haematol; 2017 Nov; 99(5):409-414. PubMed ID: 28675766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients.
    Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q
    Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of the new international staging system in multiple myeloma. Comparison with Durie-Salmon staging system].
    Conté L G; Figueroa M G; Lois V V; Cabrera C ME; León R A; García L H; Rojas R H
    Rev Med Chil; 2008 Jan; 136(1):7-12. PubMed ID: 18483648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma with unexplained isolated anaemia in a 24year old man- a case report.
    Aworanti OW; Ogundeji SP; Adeoye OA; Shokunbi WA
    Afr Health Sci; 2022 Dec; 22(4):64-69. PubMed ID: 37092066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and management of Pakistani patients with multiple myeloma.
    Shaheen H; Ghanghroo I; Malik I
    J Pak Med Assoc; 1999 Oct; 49(10):233-7. PubMed ID: 10647226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of 1027 patients with newly diagnosed multiple myeloma.
    Kyle RA; Gertz MA; Witzig TE; Lust JA; Lacy MQ; Dispenzieri A; Fonseca R; Rajkumar SV; Offord JR; Larson DR; Plevak ME; Therneau TM; Greipp PR
    Mayo Clin Proc; 2003 Jan; 78(1):21-33. PubMed ID: 12528874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-Pathological Profiles of Multiple Myeloma Patients in a Tertiary Care Hospital.
    Alam MM; Khan MA; Akter M; Wasim M; Rahman MH; Alam MN; Nahar R; Uddin MN; Kabir S; Pramanik MK; Ahmed MM; Chowdhury MAH; Basher MS; Islam GY
    Mymensingh Med J; 2024 Jul; 33(3):840-847. PubMed ID: 38944730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenting Signs of Multiple Myeloma and the Effect of Diagnostic Delay on the Prognosis.
    Goldschmidt N; Zamir L; Poperno A; Kahan NR; Paltiel O
    J Am Board Fam Med; 2016 Nov; 29(6):702-709. PubMed ID: 28076253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term survival and prognostic factors in stage II-III multiple myeloma treated with conventional chemotherapy].
    Pertuiset E; Chevret S; Lioté F; Delauche MC; Bardin T; Dryll A; Kuntz D
    Ann Med Interne (Paris); 1992; 143(8):519-24. PubMed ID: 1303595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International staging system for multiple myeloma.
    Greipp PR; San Miguel J; Durie BG; Crowley JJ; Barlogie B; Bladé J; Boccadoro M; Child JA; Avet-Loiseau H; Kyle RA; Lahuerta JJ; Ludwig H; Morgan G; Powles R; Shimizu K; Shustik C; Sonneveld P; Tosi P; Turesson I; Westin J
    J Clin Oncol; 2005 May; 23(15):3412-20. PubMed ID: 15809451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.
    Dimopoulos MA; Pouli A; Anagnostopoulos A; Repoussis P; Symeonidis A; Terpos E; Delimbasi S; Tsolakis F; Economopoulos T; Zervas C
    Leuk Lymphoma; 2006 Aug; 47(8):1553-6. PubMed ID: 16966266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of radiotherapy in the treatment of multiple myeloma].
    Mose S; Pfitzner D; Rahn A; Nierhoff C; Schiemann M; Böttcher HD
    Strahlenther Onkol; 2000 Nov; 176(11):506-12. PubMed ID: 11143524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma in elderly patients: prognostic factors and outcome.
    Anagnostopoulos A; Gika D; Symeonidis A; Zervas K; Pouli A; Repoussis P; Grigoraki V; Anagnostopoulos N; Economopoulos T; Maniatis A; Dimopoulos MA
    Eur J Haematol; 2005 Nov; 75(5):370-5. PubMed ID: 16191085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Suppressed Levels of Uninvolved Immunoglobulins on the Prognosis of Symptomatic Multiple Myeloma.
    Sarı M; Sarı S; Nalçacı M
    Turk J Haematol; 2017 Jun; 34(2):131-136. PubMed ID: 27795224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation and survival of patients with severe renal failure and myeloma.
    Irish AB; Winearls CG; Littlewood T
    QJM; 1997 Dec; 90(12):773-80. PubMed ID: 9536342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.
    Katodritou E; Verrou E; Hadjiaggelidou C; Gastari V; Laschos K; Kontovinis L; Kapetanos D; Constantinou N; Terpos E; Zervas K
    Am J Hematol; 2008 Sep; 83(9):697-701. PubMed ID: 18626886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.